A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

BACKGROUND: Hodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of second cancers (SC) and cardiac sequelae. To reduce such risks, extended-field radiotherapy (RT) for HL has largely been replaced by involved field radiotherapy (IFRT). While it has generally be...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Eng-Siew, Tran, Tu Huan, Heydarian, Mostafa, Sachs, Rainer K, Tsang, Richard W, Brenner, David J, Pintilie, Melania, Xu, Tony, Chung, June, Paul, Narinder, Hodgson, David C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847517/
https://www.ncbi.nlm.nih.gov/pubmed/17362522
http://dx.doi.org/10.1186/1748-717X-2-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847517/
https://www.ncbi.nlm.nih.gov/pubmed/17362522
http://dx.doi.org/10.1186/1748-717X-2-13

Ejemplares similares